e-learning
resources
ERJ
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
King's Brief Interstitial Lung Disease questionnaire: responsiveness and minimum clinically important difference
Claire M. Nolan, Surinder S. Birring, Matthew Maddocks, Toby M. Maher, Suhani Patel, Ruth E. Barker, Sarah E. Jones, Jessica A. Walsh, Stephanie C. Wynne, Peter M. George, William D-C. Man
Source:
Eur Respir J, 54 (3) 1900281; 10.1183/13993003.00281-2019
Journal Issue:
September
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Claire M. Nolan, Surinder S. Birring, Matthew Maddocks, Toby M. Maher, Suhani Patel, Ruth E. Barker, Sarah E. Jones, Jessica A. Walsh, Stephanie C. Wynne, Peter M. George, William D-C. Man. King's Brief Interstitial Lung Disease questionnaire: responsiveness and minimum clinically important difference. Eur Respir J, 54 (3) 1900281; 10.1183/13993003.00281-2019
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ANCA associated vasculitis and lung disease
Panel discussion on genetics in pulmonary fibrosis
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Related content which might interest you:
Validation of the King’s Brief Interstitial Lung Disease questionnaire in Danish
Source: International Congress 2018 – Consequences of idiopathic interstitial pneumonias
Year: 2018
King’s Brief Interstitial Lung Disease (K-BILD) questionnaire: content relevance in progressive fibrosing ILD (PF-ILD)
Source: Virtual Congress 2020 – Natural history and management of interstitial lung diseases of known cause
Year: 2020
Translation and validation of the King's brief interstitial lung disease (K-BILD) questionnaire in French, Italian and Dutch
Source: International Congress 2014 – ILDs 2
Year: 2014
The King’s brief interstitial lung disease (K-BILD) questionnaire; an updated minimal important difference
Source: International Congress 2016 – Clinical aspects of ILD
Year: 2016
The Severe Asthma Questionnaire: sensitivity to change and minimal clinically important difference
Source: Eur Respir J, 57 (6) 2100300; 10.1183/13993003.00300-2021
Year: 2021
Translation and preliminary validation of the KBILD QOL questionnaire to Spanish
Source: International Congress 2014 – ILDs 6
Year: 2014
The Severe Asthma Questionnaire (SAQ) - minimal clinically important difference and sensitivity to change
Source: Virtual Congress 2021 – Patient-reported outcome measures (PROMs): easy tools in the management of chronic respiratory diseases
Year: 2021
Physical activity and symptom burden in COPD: The Canadian Cohort Obstructive Lung Disease (CanCOLD) study
Source: Virtual Congress 2021 – Lung disease burden and management
Year: 2021
The Hospital Anxiety and Depression Scale (HADS) in Bronchiectasis: Response to pulmonary rehabilitation (PR) and Minimum Clinically Important Difference (MCID)
Source: International Congress 2019 – Hot topics in pulmonary rehabilitation
Year: 2019
The minimal important difference for the St George's Respiratory Questionnaire in patients with severe COPD
Source: Eur Respir J 2015; 46: 1598-1604
Year: 2015
Reliability and validity of the Chester Step Test in people with Interstitial Lung Disease.
Source: Virtual Congress 2021 – Respiratory physiotherapy: e-health, activities of daily living and measurement properties of instruments
Year: 2021
The European research collaboration for Children's Interstitial Lung Disease (ChILDEU) ERS Clinical Research Collaboration
Source: Eur Respir J, 52 (6) 1801855; 10.1183/13993003.01855-2018
Year: 2018
Correlation of King’s Sarcoidosis Questionnaire with clinical parameters
Source: Virtual Congress 2020 – Clinical issues in granulomatous lung diseases
Year: 2020
Prevalence of Anxiety Disorders and Depression in Patients with Chronic Obstructive Pulmonary Disease and correlation with the clinical stage of the disease
Source: Virtual Congress 2021 – Comorbidities in airway obstructive diseases
Year: 2021
Short telomere length and its association with risk for COPD and emphysema severity: Korean Obstructive Lung Disease (KOLD) cohort study
Source: International Congress 2017 – Markers of COPD progression
Year: 2017
Health Related Quality of Life in children with Paediatric Central Airway Obstructive Disease (PCAOD) assessed by PACQLQ and TAPQOL questionnaires
Source: International Congress 2017 – Paediatric bronchology in clinical practice
Year: 2017
Lung Cancer Screening Programs: a missed “window” to diagnose Obstructive Lung Disease. The NLST-ACRIN experience.
Source: International Congress 2018 – Interdependence of COPD and comorbidities and the underlying mechanisms
Year: 2018
Assessing sarcoidosis: The King‘s Sarcoidosis Questionnaire and the minimal important difference
Source: Annual Congress 2012 - Cystic lung diseases: lung granulomatosis
Year: 2012
The minimal clinically important difference of the Severe Respiratory Insufficiency questionnaire.
Source: International Congress 2018 – Non-invasive ventilation in chronic respiratory failure
Year: 2018
Evaluation of three dyspnea questionnaires in the progression of Interstitial Lung Diseases.
Source: Virtual Congress 2021 – Interstitial lung disease around the world
Year: 2021
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept